Charles Cherington insider trades

Open-market stock purchases and sales by Charles Cherington, 10% Owner at Ernexa Therapeutics Inc, from SEC Form 4 filings since Jun 1, 2021.

Track record: 40% of 5 scored buys are up 5% or more since purchase, averaging +3%.

Recent trades

DateStockTradeValue
Feb 10, 2026ERNA Ernexa Therapeutics IncBought$2.7M

Companies traded

  • ERNA Ernexa Therapeutics Inc: 24 buys, 8 sales, last Feb 10, 2026
  • CMRA Comera Life Sciences Holdings, Inc: 15 buys, last Dec 29, 2023
  • BTX Brooklyn ImmunoTherapeutics, Inc: 3 sales, last Aug 1, 2022

Get free alerts when Charles Cherington files a new trade →